Company Filing History:
Years Active: 2001-2003
Title: Innovations of Frederick Meins, Jr.
Introduction
Frederick Meins, Jr. is a notable inventor based in Riehen, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the area of plant genetics. With a focus on enhancing disease resistance in plants, his work has implications for agricultural innovation.
Latest Patents
Frederick Meins, Jr. holds 2 patents related to DNA sequences encoding polypeptides with beta-1,3-glucanase activity. His inventions provide chemically regulatable DNA sequences capable of regulating transcription in plants or plant tissues. These sequences are derived from the 5' region of genes encoding pathogenesis-related (PR) proteins. The inventions also include anti-pathogenic sequences derived from novel cDNAs coding for PR proteins, which can be genetically engineered into plants to enhance their resistance to diseases. Additionally, he has developed methods for the exogenous regulation of gene expression in plants, which involve applying chemical regulators to plants at specific times to control gene expression.
Career Highlights
Frederick Meins, Jr. is associated with Novartis Finance Corporation, where he continues to contribute to advancements in plant biotechnology. His work is pivotal in developing innovative solutions for agricultural challenges.
Collaborations
He has collaborated with notable colleagues, including Hideaki Shinshi and Herman C. Wenzler, to further his research and innovations in the field.
Conclusion
Frederick Meins, Jr. is a prominent figure in the realm of plant biotechnology, with a focus on enhancing disease resistance through innovative genetic solutions. His contributions are vital for the future of agricultural practices.